This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Profhilo® is a well-known characterized formulation of thermally stabilized hybrid cooperative complexes (HCC) that enables the delivery of high concentration (32 mg/mL) of low and high molecular weight hyaluronic acid (HA) when injected in the skin dermis to treat skin laxity and reverse the signs of ageing. The aim of this study was to compare the efficacy and safety outcomes of Profhilo® used for facial and neck rejuvenation in separate cohorts of Chinese and Caucasian subjects by comparing the results of 3 clinical studies.METHODS: For the face, main outcomes (Wrinkle Severity Rate Scale [WSRS] and Facial Volume Loss Scale [FVLS]) at TW4 and TW8 after Profhilo® treatment were compared. For the neck, IBSA Neck Skin Laxity Scale results at TW4 and TW8 between the two ethnicities were chosen to be examined.RESULTS: The Chinese population showed overall better baseline scores. As to WSRS, at TW8 Chinese individuals showed a reduction of 29%, compared to -12% in Caucasian ones. As to FVLS, the Chinese population had a decrease of 48% compared to -21% in Caucasians. As to Neck Skin Laxity Clinical Score, the Chinese group diminished of 46% compared to -21% recorded in the Caucasian ethnicity.CONCLUSIONS: Treatment with Profhilo® showed to be beneficial for neck and face rejuvenation in both populations examined. However, Chinese subjects seemed to respond more rapidly and effectively than Caucasian ones. Genetic and molecular differences of skin tissues in addition to muscle and bone anthropometric variations related to ethnicity may result in a more favorable baseline and efficacy outcomes of Profhilo® treatment in Chinese patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sparavigna et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: